KalVista Pharmaceuticals, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4834971032
USD
16.40
2.88 (21.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Apr'25
Jan'25
Oct'24
Jul'24
Apr'24
Jan'24
Oct'23
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Raw Material Cost
0.26
0.23
0.23
0.22
0.22
0.21
0.20
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.94
2.84
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
38.88
30.12
28.97
17.38
22.99
10.42
10.46
Other Expenses
1.29
0.98
1.66
2.66
2.52
2.25
1.91
Total Expenditure (Excl Depreciation)
55.03
42.94
45.81
44.21
48.45
33.15
29.75
Operating Profit (PBDIT) excl Other Income
-55
-42.9
-45.8
-44.2
-48.5
-33.199999999999996
-29.700000000000003
Other Income
6.50
1.52
3.54
3.77
3.81
4.12
2.10
Operating Profit (PBDIT)
-48.27
-41.19
-42.04
-40.22
-44.43
-28.82
-27.45
Interest
2.94
2.84
0.00
0.00
0.00
0.00
0.00
Exceptional Items
-1.61
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
-0.26
-0.23
-0.23
-0.22
-0.22
-0.21
-0.20
Depreciation
0.26
0.23
0.23
0.22
0.22
0.21
0.20
Profit Before Tax
-53.08
-44.26
-42.27
-40.44
-44.65
-29.03
-27.65
Tax
-0.85
4.25
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-52.23
-48.51
-42.27
-40.44
-44.65
-29.03
-27.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-52.23
-48.51
-42.27
-40.44
-44.65
-29.03
-27.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-52.23
-48.51
-42.27
-40.44
-44.65
-29.03
-27.65
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
95.39
145.13
133.99
172.80
206.58
88.58
114.45
Earnings per share (EPS)
-1.05
-0.92
-0.91
-0.87
-1.02
-0.84
-0.8
Diluted Earnings per share
-1.05
-0.92
-0.91
-0.87
-1.02
-0.84
-0.8
Operating Profit Margin (Excl OI)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Gross Profit Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
PAT Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Apr 2025 is 0.00% vs 0.00% in Apr 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Apr 2025 is -17.04% vs -69.58% in Apr 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Apr 2025 is -13.69% vs -53.50% in Apr 2024

stock-summary

Interest

YoY Growth in quarter ended Apr 2025 is 0.00% vs 0.00% in Apr 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Apr 2025 has improved from Apr 2024

Compare Quarterly Results Of KalVista Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
0.00
0.00
0.00
Raw Material Cost
0.26
0.31
-0.05
-16.13%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.94
0.00
2.94
Selling and Distribution Expenses
38.88
8.21
30.67
373.57%
Other Expenses
1.29
3.05
-1.76
-57.70%
Total Expenditure (Excl Depreciation)
55.03
39.06
15.97
40.89%
Operating Profit (PBDIT) excl Other Income
-55.03
-39.06
-15.97
-40.89%
Other Income
6.50
2.71
3.79
139.85%
Operating Profit (PBDIT)
-48.27
-36.04
-12.23
-33.93%
Interest
2.94
0.00
2.94
Exceptional Items
-1.61
0.00
-1.61
Gross Profit (PBDT)
-0.26
-0.31
0.05
16.13%
Depreciation
0.26
0.31
-0.05
-16.13%
Profit Before Tax
-53.08
-36.35
-16.73
-46.02%
Tax
-0.85
0.00
-0.85
Provisions and contingencies
0
0
0.00
Profit After Tax
-52.23
-36.35
-15.88
-43.69%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-52.23
-36.35
-15.88
-43.69%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-52.23
-36.35
-15.88
-43.69%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
95.39
324.00
-228.61
-70.56%
Earnings per share (EPS)
-1.05
-0.47
-0.58
-123.40%
Diluted Earnings per share
-1.05
-0.47
-0.58
-123.40%
Operating Profit Margin (Excl OI)
0.00%
0.00%
0.00
0.00%
Gross Profit Margin
0.00%
0.00%
0.00
0.00%
PAT Margin
0.00%
0.00%
0.00
0.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Markets Mojo
No Net Sales in the last few periods
Quarterly - Consolidate Net Profit
Consolidate Net Profit -5.22 Million
in Apr 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Apr 2025 is -7.63% vs -14.66% in Jan 2025

stock-summary

YoY Growth in quarter ended Apr 2025 is -17.04% vs -69.58% in Apr 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -5.48 Million
in Apr 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Apr 2025 is -28.34% vs 6.36% in Jan 2025

stock-summary

YoY Growth in quarter ended Apr 2025 is -13.69% vs -53.50% in Apr 2024

Quarterly - Interest
Interest 0.29 Million
in Apr 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Apr 2025 is 3.57% vs 0.00% in Jan 2025

stock-summary

YoY Growth in quarter ended Apr 2025 is 0.00% vs 0.00% in Apr 2024

Quarterly - Operating Profit Margin (Excl OI)
Markets Mojo
No Operating Profit Margin (Excl OI) in the last few periods